Cargando…

The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 “doublethink” effect

The neutralization assays are considered the gold-standard being capable of evaluating and detecting, functional antibodies. To date, many different protocols exist for micro-neutralization (MN) assay which varies in several steps: cell number and seeding conditions, virus amount used in the infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manenti, Alessandro, Molesti, Eleonora, Maggetti, Marta, Torelli, Alessandro, Lapini, Giulia, Montomoli, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364219/ https://www.ncbi.nlm.nih.gov/pubmed/34403775 http://dx.doi.org/10.1016/j.jviromet.2021.114261

Ejemplares similares

Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples
por: Manenti, Alessandro, et al.
Publicado: (2020)

Discordant Correlation between Serological Assays Observed When Measuring Heterosubtypic Responses against Avian Influenza H5 and H7 Viruses in Unexposed Individuals
por: Molesti, Eleonora, et al.
Publicado: (2014)

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
por: Mazzini, Livia, et al.
Publicado: (2021)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

Doublethink and scale mismatch polarize policies for an invasive tree
por: Roberts, Caleb P., et al.
Publicado: (2018)

Use of lentiviral pseudotypes as an alternative to reassortant or Triton X‐100‐treated wild‐type Influenza viruses in the neuraminidase inhibition enzyme‐linked lectin assay
por: Biuso, Fabrizio, et al.
Publicado: (2019)

There is Room for Even More Doublethink: The Perilous Status of Psychoanalytic Research
por: Fonagy, Peter
Publicado: (2013)

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
por: Dapporto, Francesca, et al.
Publicado: (2022)

The “g” in Faking: Doublethink the Validity of Personality Self-Report Measures for Applicant Selection
por: Geiger, Mattis, et al.
Publicado: (2018)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
por: Dapporto, Francesca, et al.
Publicado: (2022)

SARS-CoV-2 Seroconversion and Pregnancy Outcomes in a Population of Pregnant Women Recruited in Milan, Italy, between April 2020 and October 2020
por: Accurti, Veronica, et al.
Publicado: (2022)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network
por: Gianchecchi, Elena, et al.
Publicado: (2016)

Influenza Anti-Stalk Antibodies: Development of a New Method for the Evaluation of the Immune Responses to Universal Vaccine
por: Manenti, Alessandro, et al.
Publicado: (2020)

Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
por: Marchi, Serena, et al.
Publicado: (2021)

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults
por: Montomoli, Emanuele, et al.
Publicado: (2018)

Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
por: Gianchecchi, Elena, et al.
Publicado: (2022)

Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix® vaccination
por: Ambati, Aditya, et al.
Publicado: (2015)

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
por: Manenti, Alessandro, et al.
Publicado: (2022)

Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
por: Trombetta, Claudia Maria, et al.
Publicado: (2021)

Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose
por: Mangia, Alessandra, et al.
Publicado: (2022)

Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection
por: Manenti, Alessandro, et al.
Publicado: (2023)

Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
por: Gianchecchi, Elena, et al.
Publicado: (2023)

How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions
por: Gianchecchi, Elena, et al.
Publicado: (2019)

Rectal Administration of Leishmania Cells Elicits a Specific, Th1-Associated IgG2a Response in Mice: New Perspectives for Mucosal Vaccination against Leishmaniasis, after the Repurposing of a Study on an Anti-Viral Vaccine Candidate
por: Varotto-Boccazzi, Ilaria, et al.
Publicado: (2023)

Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
por: Landry, Nathalie, et al.
Publicado: (2010)

Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses
por: Trombetta, Claudia Maria, et al.
Publicado: (2018)

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2021)

Analytical and clinical performance of cPass neutralizing antibodies assay
por: Jung, Joanna, et al.
Publicado: (2021)

Multiplex Evaluation of Influenza Neutralizing Antibodies with Potential Applicability to In-Field Serological Studies
por: Molesti, Eleonora, et al.
Publicado: (2014)

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2020)

Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections
por: Bandi, Claudio, et al.
Publicado: (2023)

Comparative Serological Assays for the Study of H5 and H7 Avian Influenza Viruses
por: Molesti, Eleonora, et al.
Publicado: (2013)

Detection of rabies viral neutralizing antibodies in the Puerto Rican Brachyphylla cavernarum
por: Hirsbrunner, Andrew, et al.
Publicado: (2020)

Neutral Theory and Rapidly Evolving Viral Pathogens
por: Frost, Simon D W, et al.
Publicado: (2018)

Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry
por: Long, Jason, et al.
Publicado: (2015)

Epidemic Preparedness—Leishmania tarentolae as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19
por: Varotto-Boccazzi, Ilaria, et al.
Publicado: (2021)

Sea buckthorn bud extract displays activity against cell-cultured Influenza virus
por: TORELLI, A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2nua3md6i40me759cg0vf39aib